Sulphonamides Market Size (2024 - 2029)

Sulphonamides Market Analysis

The sulphonamides market is anticipated to record a CAGR of nearly 4.1% over the forecast period.

The COVID-19 pandemic had a substantial impact on the market due to supply chain disruptions and pandemic-related restrictions worldwide. However, initially, many antibiotics were used to treat COVID-19, which were widely prescribed and studied as the COVID-19 remedy. During the COVID-19 outbreak, antibiotics were used to improve public health and decrease the potential of other infectious exposures. An article published by Bioorganic & Medicinal Chemistry Letters in January 2021 stated that a novel class of cyclic sulfonamide derivatives acted as a promising new template for SARS-CoV-2 inhibitors using structural activity relationship optimization, viral inhibitory assays, cytotoxicity assays, and pharmacokinetic studies. Thus, the sulphonamides market is expected to grow due to an increasing number of studies on various sulfonamide derivatives used to treat COVID-19 infections.

Certain factors that are driving the market's growth include the increasing prevalence of chronic diseases worldwide and growing R&D activities in pharmaceutical companies. As per an article published by JEADV in March 2022, more than 94 million Europeans complain of uncomfortable skin sensations like itching, burning, or dryness. The most frequently reported conditions were fungal skin infections (8.9%), acne (5.4%), and atopic dermatitis or eczema (5.5%). Alopecia, acne, eczema, and rosacea were more common in women, whereas men were more likely to suffer from psoriasis and sexually transmitted infections (STIs). Similarly, there is a high prevalence of the diverse range of skin infections, gastrointestinal tract (GIT) infections, urinary tract infections, and respiratory tract infections globally. For instance, as per the report published by Verywell Health in November 2022, urinary tract infection (UTI) is an infection of the urinary system, which can affect the bladder (cystitis), urethra (urethritis), or kidneys (pyelonephritis), and 6 in 10 women in the United States experienced a UTI.

There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics, and combinatorial chemistry, for better drug candidate identification. Drug discovery has evolved significantly with emerging technologies, helping the process become more refined, accurate, and less time-consuming. However, increasing side effects associated with the use of sulfa drugs and the availability of substitute drugs may hinder the market's growth over the forecast period.

Sulphonamides Industry Segmentation

As per the scope of the report, sulfonamides refer to the sulfa-related group of antibiotics, which are used to treat bacterial infections and some fungal infections. Sulfa drugs kill bacteria and fungi by interfering with cell metabolism. 

The sulphonamides market is segmented by route of administration (oral, topical, and other routes of administration), application (skin infection, gastro-intestinal tract (GIT) infection, urinary tract infection (UTI), respiratory tract infection (RTI), and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.